Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Director's Cut Debuts: CardioWest Artificial Heart Implant Surgery 4X Longer Than Original Video Available on National Geographic Website.


Hospital Featured in Video Has Implanted 15 Artificial Hearts in 2007

TUCSON, Ariz. -- SynCardia Systems, Inc., manufacturer of the CardioWest[TM] temporary Total Artificial Heart (TAH-t), has released a new time-lapse version of the CardioWest implant surgery shot for National Geographic Magazine The National Geographic Magazine, later shortened to National Geographic, is the official journal of the National Geographic Society. It published its first issue in 1888, just nine months after the Society itself was founded. . SynCardia's director's cut director's cut
n.
The version of a film in which the editing process is overseen, executed, or approved by the director, usually including footage not included in the standard release.
 is almost four times longer than the original 35-second video, featured on National Geographic Magazine's website. The director's cut allows viewers to see more of how this life-saving surgery is performed. See director's cut

The 2:02 video features the surgical team from the German Heart Institute Berlin and Prof. Roland Hetzer, M.D., implanting a CardioWest temporary artificial heart into 62-year-old Siegfried Streiter. Streiter was discharged on the portable driver to wait for a donor heart for transplant.

"We believe there are three times more hearts being implanted in Europe today because of the TAH-t portable driver," said Rodger Ford, SynCardia president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Discharge virtually eliminates in-hospital recovery costs for stable TAH-t patients. It allows them to lead near normal lives with their family and friends while they wait for a donor heart. SynCardia is working with the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 to address the need for a discharge driver in the U.S."

As of Nov. 7, Prof. Hetzer and the German Heart Institute Berlin have implanted 15 artificial hearts this year. With two months left in 2007, they have surpassed their previous totals for the last three years combined. The German Heart Institute leads all CardioWest certified centers in implants this year.

"Patients with predominant right heart failure and those with profound cardiogenic shock cardiogenic shock
n.
Shock resulting from a decline in cardiac output that occurs as a result of serious heart disease, especially myocardial infarction.
 have a realistic chance to survive with a TAH-t, which is superior to any other method," said Prof. Hetzer. "The CardioWest TAH-t is the only device of this kind available today."

Since July 16, 2006, stable TAH-t patients in Europe have been able to recover at home thanks to the CE approved TAH-t portable driver. The driver powers the TAH-t with precisely calibrated cal·i·brate  
tr.v. cal·i·brat·ed, cal·i·brat·ing, cal·i·brates
1. To check, adjust, or determine by comparison with a standard (the graduations of a quantitative measuring instrument):
 pulses of air and monitors artificial heart performance.

The CardioWest TAH-t is the only FDA and CE approved temporary Total Artificial Heart in the world. Originally designed as a permanent replacement heart, it is currently approved as a bridge to transplant for patients dying from end stage biventricular failure.

The pivotal clinical study of the TAH-t published in the New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world.  (NEJM NEJM New England Journal of Medicine  2004; 351: 859-867) showed that 79 percent of patients receiving the TAH-t survived to transplant, the highest survival rate for any device in the world.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Website overview
Date:Nov 14, 2007
Words:413
Previous Article:Cook Medical Introduces the 36mm Diameter Zenith Renu(R) AAA Ancillary Graft at the 34th Annual VEITHsymposium.
Next Article:Pro-Pharmaceuticals Reports Third Quarter Results.
Topics:



Related Articles
STRONG ACTING CAN'T RESCUE DULL 'DEAL'.
SEASON'S SCREENINGS.
Hope for Isabelle.
One student's view: the Jesse Brown Memorial Youth Scholarship.
Do You Manic? How Speed Reading Can Make You Happy! by Jackie Alan Giuliano, Ph.D. and H. Bernard Wechsler
What Does Natural Health Mean to You?

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles